OVERVIEW OF SCIENCE AT IMCB
IMCB drives cutting-edge research in four key areas: Cancer Signalling & Therapy, Cellular Engineering & Therapy, Biomolecular Engineering & Technologies, and Neurometabolism in Health & Disease. This multifaceted approach underscores IMCB’s commitment to translating fundamental research into impactful clinical applications and unlocking new possibilities for prevention and treatment. By fostering a collaborative and interdisciplinary environment, IMCB accelerates the discovery of innovative solutions to complex health challenges.
Research Divisions

IMCB’s Research Divisions span four key strategic domains:
- Cancer Signalling & Therapy : Understanding cancer cell signalling and metabolism to develop innovative therapies.
- Cellular Engineering & Therapy : Investigating brain-body interactions, neurometabolism, and cognitive decline to uncover new therapeutic targets.
- Biomolecular Engineering & Technologies : Designing and engineering biomolecules and enabling technologies to create new research tools, diagnostics and therapeutic modalities.
- Neurometabolism in Health & Disease : Investigating brain-body interactions, neurometabolism, and cognitive decline to uncover new therapeutic targets.